Li, Xingchen
Tian, Wenzhi
Jiang, Zhongxing
Song, Yongping
Leng, Xiangyang
Yu, Jifeng http://orcid.org/0000-0003-1217-4385
Funding for this research was provided by:
Science and Technology Department of Henan Province (LHGJ20190039, SBGJ20202076)
Zhengzhou Municipal Science and Technology Bureau (XTCX2023010)
Article History
Received: 2 July 2023
Accepted: 7 December 2023
First Online: 27 January 2024
Declarations
:
: W.T. is the founder of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. All other authors declared no conflicts of interest.